GlycanAge
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$52.9M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
GlycanAge is a biotech company that provides a biological age test designed to discover, measure, and optimize longevity by analyzing glycan biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GlycanAge Comparables
Compare GlycanAge with similar companies based on industry and business-model similarity.
No public comparables are available for GlycanAge. Request access to learn about comparables coverage.
Request accessGlycanAge Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Seed | Feb 19, 2024 |
Key People
Founding team and executive leadership
GlycanAge Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| LaunchHub Ventures | Series A |
| Lightfield Equity | Series A |
| South Central Ventures | Series A |
| BrightCap Ventures | Series A |
| Vesna Deep Tech Fund | Series A |
| Guinness Ventures | Series A |
| Kadmos Capital | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$9M round closed
- Feb 19, 2024
$4M round led by Kadmos Capital and LAUNCHub Ventures
Recent news
Latest coverage and updates
- partners_withAug 20, 2026
GlycanAge Ltd. partnered with ExoEarth corp. on Aug 20th '26.
GlycanAge Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GlycanAge's valuation, stock price, and market status.
Is GlycanAge a public or private company?
GlycanAge is a private company.
What is the current stock price of GlycanAge?
GlycanAge is a private company with no public stock price. Caplight tracks GlycanAge's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is GlycanAge worth (valuation)?
Valuation information for GlycanAge is not publicly available.
Can I buy GlycanAge stock?
GlycanAge shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GlycanAge's last funding round?
GlycanAge's most recent funding round was Series A on December 18, 2025.
Who are the main investors in GlycanAge?
Key investors in GlycanAge include Kadmos Capital, LAUNCHub Ventures, Fifth Quarter Ventures.
Will GlycanAge IPO soon?
No public IPO plans have been announced for GlycanAge.
How can I track GlycanAge secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GlycanAge's secondary market activity and sign up for updates.